<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>The Access Problem | The Headache Vault</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@600;700;800&family=Source+Sans+3:wght@400;500;600&display=swap" rel="stylesheet">
    <style>
        :root {
            --purple-deep: #2D1B4E;
            --purple-primary: #5B3E8C;
            --purple-mid: #7E5BAE;
            --purple-light: #A88BD4;
            --purple-pale: #E8DFF5;
            --white: #FFFFFF;
            --gray-100: #F8F7FA;
            --gray-600: #6B6B7B;
            --red-accent: #C0392B;
            --red-light: #FADBD8;
            --amber-accent: #D4A017;
            --amber-light: #FEF9E7;
            --font-heading: 'Montserrat', sans-serif;
            --font-body: 'Source Sans 3', sans-serif;
        }

        * { margin: 0; padding: 0; box-sizing: border-box; }
        html { scroll-behavior: smooth; }

        body {
            font-family: var(--font-body);
            background: var(--white);
            color: var(--purple-deep);
            line-height: 1.6;
        }

        /* Header - matches main site */
        header {
            position: fixed;
            top: 0;
            width: 100%;
            padding: 1rem 4rem;
            display: flex;
            justify-content: space-between;
            align-items: center;
            background: rgba(255,255,255,0.95);
            backdrop-filter: blur(10px);
            border-bottom: 1px solid var(--purple-pale);
            z-index: 100;
        }

        .logo {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            text-decoration: none;
        }

        .logo-icon {
            width: 40px;
            height: 40px;
            background: linear-gradient(135deg, var(--purple-primary), var(--purple-mid));
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            color: white;
            font-size: 1.25rem;
        }

        .logo-text {
            font-family: var(--font-heading);
            font-weight: 700;
            font-size: 1.25rem;
            color: var(--purple-deep);
        }

        nav {
            display: flex;
            gap: 2rem;
            align-items: center;
        }

        nav a {
            color: var(--gray-600);
            text-decoration: none;
            font-weight: 500;
            transition: color 0.3s;
        }

        nav a:hover { color: var(--purple-primary); }

        .btn {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            padding: 0.75rem 1.5rem;
            border-radius: 8px;
            font-weight: 600;
            font-size: 0.95rem;
            text-decoration: none;
            transition: all 0.3s ease;
            cursor: pointer;
            border: none;
        }

        .btn-primary {
            background: linear-gradient(135deg, var(--purple-primary), var(--purple-mid));
            color: white;
            box-shadow: 0 4px 15px rgba(91, 62, 140, 0.3);
        }

        .btn-primary:hover {
            transform: translateY(-2px);
            box-shadow: 0 6px 20px rgba(91, 62, 140, 0.4);
        }

        /* Hero */
        .page-hero {
            padding: 10rem 4rem 4rem;
            background: linear-gradient(180deg, var(--gray-100) 0%, var(--white) 100%);
            text-align: center;
            position: relative;
            overflow: hidden;
        }

        .page-hero::before {
            content: '';
            position: absolute;
            top: -30%;
            left: 50%;
            transform: translateX(-50%);
            width: 120%;
            height: 120%;
            background: radial-gradient(ellipse, rgba(192, 57, 43, 0.04) 0%, transparent 60%);
            pointer-events: none;
        }

        .page-hero h1 {
            font-family: var(--font-heading);
            font-size: clamp(2rem, 4.5vw, 3rem);
            font-weight: 800;
            line-height: 1.2;
            margin-bottom: 1.25rem;
            color: var(--purple-deep);
            position: relative;
        }

        .page-hero h1 span {
            color: var(--red-accent);
        }

        .page-hero .subtitle {
            font-size: 1.2rem;
            color: var(--gray-600);
            max-width: 700px;
            margin: 0 auto 1rem;
            line-height: 1.7;
        }

        .page-hero .hero-stat {
            font-family: var(--font-heading);
            font-size: 1.15rem;
            font-weight: 700;
            color: var(--purple-primary);
            margin-top: 1.5rem;
        }

        /* Cascade Section */
        .cascade-section {
            padding: 4rem 4rem 3rem;
            max-width: 960px;
            margin: 0 auto;
        }

        .cascade-section .section-intro {
            text-align: center;
            margin-bottom: 3rem;
        }

        .cascade-section .section-intro h2 {
            font-family: var(--font-heading);
            font-size: 1.85rem;
            font-weight: 700;
            margin-bottom: 0.75rem;
        }

        .cascade-section .section-intro p {
            color: var(--gray-600);
            max-width: 640px;
            margin: 0 auto;
            font-size: 1.05rem;
        }

        /* Funnel Visual */
        .funnel {
            display: flex;
            flex-direction: column;
            gap: 0;
            margin-bottom: 3rem;
        }

        .funnel-step {
            display: grid;
            grid-template-columns: 1fr auto 1fr;
            align-items: center;
            gap: 1.5rem;
            position: relative;
        }

        .funnel-bar-container {
            display: flex;
            flex-direction: column;
            align-items: center;
        }

        .funnel-bar {
            height: 54px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-family: var(--font-heading);
            font-weight: 700;
            font-size: 1.1rem;
            color: white;
            transition: all 0.4s ease;
            position: relative;
            cursor: pointer;
        }

        .funnel-bar:hover {
            transform: scaleY(1.06);
            box-shadow: 0 4px 20px rgba(0,0,0,0.15);
        }

        .funnel-bar.clickable::after {
            content: 'â–¾ Details';
            position: absolute;
            bottom: -18px;
            font-size: 0.65rem;
            font-weight: 600;
            color: var(--purple-mid);
            opacity: 0;
            transition: opacity 0.3s;
        }

        .funnel-bar.clickable:hover::after {
            opacity: 1;
        }

        .funnel-label-left {
            text-align: right;
            font-size: 0.95rem;
            color: var(--gray-600);
        }

        .funnel-label-right {
            text-align: left;
        }

        .funnel-label-right .dropoff {
            font-family: var(--font-heading);
            font-weight: 700;
            font-size: 0.95rem;
            color: var(--red-accent);
        }

        .funnel-label-right .driver {
            font-size: 0.85rem;
            color: var(--gray-600);
            display: block;
            margin-top: 0.1rem;
        }

        .funnel-connector {
            width: 2px;
            height: 14px;
            background: var(--purple-pale);
            margin: 0 auto;
        }

        /* Bottom line callout */
        .bottom-line {
            background: var(--purple-deep);
            border-radius: 16px;
            padding: 2.5rem 3rem;
            text-align: center;
            color: white;
            margin-bottom: 3rem;
        }

        .bottom-line .big-ratio {
            font-family: var(--font-heading);
            font-size: clamp(2.5rem, 5vw, 3.5rem);
            font-weight: 800;
            color: var(--purple-light);
            margin-bottom: 0.5rem;
        }

        .bottom-line p {
            font-size: 1.1rem;
            opacity: 0.9;
            max-width: 560px;
            margin: 0 auto;
            line-height: 1.6;
        }

        /* Map Section */
        .map-section {
            padding: 4rem 4rem;
            background: var(--gray-100);
        }

        .section-header {
            text-align: center;
            margin-bottom: 2.5rem;
        }

        .section-header h2 {
            font-family: var(--font-heading);
            font-size: 1.85rem;
            font-weight: 700;
            margin-bottom: 0.75rem;
        }

        .section-header p {
            color: var(--gray-600);
            max-width: 600px;
            margin: 0 auto;
        }

        .map-container {
            max-width: 1000px;
            margin: 0 auto;
            border-radius: 16px;
            overflow: hidden;
            box-shadow: 0 10px 40px rgba(45, 27, 78, 0.15);
            border: 1px solid var(--purple-pale);
        }

        .map-container iframe {
            width: 100%;
            height: 550px;
            border: none;
            display: block;
        }

        .map-caption {
            text-align: center;
            margin-top: 1.25rem;
            color: var(--gray-600);
            font-size: 0.9rem;
        }

        /* Detail Panels */
        .stage-details {
            padding: 0 4rem 4rem;
            max-width: 960px;
            margin: 0 auto;
        }

        .stage-panel {
            border: 1px solid var(--purple-pale);
            border-radius: 16px;
            margin-bottom: 1.25rem;
            overflow: hidden;
            transition: box-shadow 0.3s;
        }

        .stage-panel:hover {
            box-shadow: 0 4px 20px rgba(91, 62, 140, 0.08);
        }

        .stage-toggle {
            width: 100%;
            background: none;
            border: none;
            padding: 1.25rem 1.75rem;
            display: flex;
            align-items: center;
            gap: 1rem;
            cursor: pointer;
            font-family: var(--font-body);
            text-align: left;
            transition: background 0.2s;
        }

        .stage-toggle:hover {
            background: var(--gray-100);
        }

        .stage-number {
            width: 36px;
            height: 36px;
            border-radius: 50%;
            background: linear-gradient(135deg, var(--purple-primary), var(--purple-mid));
            color: white;
            display: flex;
            align-items: center;
            justify-content: center;
            font-family: var(--font-heading);
            font-weight: 700;
            font-size: 0.9rem;
            flex-shrink: 0;
        }

        .stage-toggle-text {
            flex: 1;
        }

        .stage-toggle-text h3 {
            font-family: var(--font-heading);
            font-size: 1.05rem;
            font-weight: 700;
            color: var(--purple-deep);
        }

        .stage-toggle-text .stage-subtitle {
            font-size: 0.88rem;
            color: var(--gray-600);
            margin-top: 0.15rem;
        }

        .stage-arrow {
            font-size: 1.2rem;
            color: var(--purple-mid);
            transition: transform 0.3s;
            flex-shrink: 0;
        }

        .stage-panel.open .stage-arrow {
            transform: rotate(180deg);
        }

        .stage-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.4s ease;
        }

        .stage-panel.open .stage-content {
            max-height: 2000px;
        }

        .stage-content-inner {
            padding: 0 1.75rem 1.75rem;
        }

        .barrier-item {
            display: grid;
            grid-template-columns: 1fr auto;
            gap: 1rem;
            padding: 1rem 0;
            border-bottom: 1px solid var(--purple-pale);
            align-items: start;
        }

        .barrier-item:last-child {
            border-bottom: none;
        }

        .barrier-name {
            font-weight: 600;
            font-size: 0.95rem;
            color: var(--purple-deep);
            margin-bottom: 0.25rem;
        }

        .barrier-impact {
            font-size: 0.88rem;
            color: var(--gray-600);
            line-height: 1.5;
        }

        .barrier-source {
            font-size: 0.75rem;
            color: var(--purple-mid);
            font-style: italic;
            text-align: right;
            white-space: nowrap;
            align-self: center;
        }

        /* Sources */
        .sources-section {
            padding: 3rem 4rem;
            background: var(--gray-100);
            max-width: 100%;
        }

        .sources-inner {
            max-width: 960px;
            margin: 0 auto;
        }

        .sources-inner h2 {
            font-family: var(--font-heading);
            font-size: 1.25rem;
            font-weight: 700;
            margin-bottom: 1rem;
            color: var(--purple-deep);
        }

        .sources-inner p {
            font-size: 0.85rem;
            color: var(--gray-600);
            line-height: 1.8;
        }

        /* CTA */
        .page-cta {
            padding: 4rem;
            background: linear-gradient(135deg, var(--purple-deep) 0%, var(--purple-primary) 100%);
            text-align: center;
            color: white;
        }

        .page-cta h2 {
            font-family: var(--font-heading);
            font-size: 2rem;
            font-weight: 700;
            margin-bottom: 1rem;
        }

        .page-cta p {
            opacity: 0.9;
            margin-bottom: 2rem;
            max-width: 520px;
            margin-left: auto;
            margin-right: auto;
        }

        .btn-white {
            background: white;
            color: var(--purple-primary);
            font-weight: 700;
            padding: 1rem 2rem;
            font-size: 1.05rem;
        }

        .btn-white:hover {
            background: var(--purple-pale);
            transform: translateY(-2px);
        }

        /* Footer */
        footer {
            padding: 2rem 4rem;
            text-align: center;
            background: var(--purple-deep);
            color: rgba(255,255,255,0.6);
            font-size: 0.85rem;
        }

        footer a {
            color: var(--purple-light);
            text-decoration: none;
        }

        /* Responsive */
        @media (max-width: 768px) {
            header { padding: 1rem 1.5rem; }
            nav { gap: 1rem; }
            nav a:not(.btn) { display: none; }
            .page-hero { padding: 8rem 1.5rem 3rem; }
            .cascade-section { padding: 3rem 1.5rem 2rem; }
            .stage-details { padding: 0 1.5rem 3rem; }
            .sources-section { padding: 2rem 1.5rem; }
            .page-cta { padding: 3rem 1.5rem; }

            .funnel-step {
                grid-template-columns: 1fr;
                gap: 0.25rem;
                text-align: center;
            }
            .funnel-label-left,
            .funnel-label-right { text-align: center; }
            .funnel-bar { min-height: 44px; font-size: 0.95rem; }

            .barrier-item {
                grid-template-columns: 1fr;
            }
            .barrier-source {
                text-align: left;
            }
            .bottom-line { padding: 2rem 1.5rem; }
        }

        /* Animation */
        .fade-in {
            opacity: 0;
            transform: translateY(20px);
            transition: opacity 0.6s ease, transform 0.6s ease;
        }
        .fade-in.visible {
            opacity: 1;
            transform: translateY(0);
        }
    </style>
</head>
<body>
    <header>
        <a href="index.html" class="logo">
            <div class="logo-icon">ðŸ”“</div>
            <span class="logo-text">The Headache Vault</span>
        </a>
        <nav>
            <a href="index.html">Home</a>
            <a href="index.html#features">Features</a>
            <a href="index.html#pricing">Pricing</a>
            <a href="index.html#demo" class="btn btn-primary">Try Beta Demo</a>
        </nav>
    </header>

    <main>
        <section class="page-hero">
            <h1>Over 7 Million Americans Need Advanced Migraine Treatment.<br><span>Only 575,000</span> Are Getting It.</h1>
            <p class="subtitle">For the 7â€“10 million patients who've failed other therapies and are clinically appropriate for CGRP/gepant medications, the problem isn't the drugs â€” it's the gauntlet of administrative, financial, and systemic barriers standing between them and relief.</p>
            <p class="hero-stat">Roughly 1 in 14 clinically appropriate patients is on continuous CGRP/gepant therapy.</p>
        </section>

        <section class="cascade-section">
            <div class="section-intro fade-in">
                <h2>The Compounding Cascade</h2>
                <p>Each stage of the treatment journey loses patients. The barriers compound â€” and the system's most modifiable failures sit right in the middle.</p>
            </div>

            <div class="funnel fade-in">
                <!-- Step 1 -->
                <div class="funnel-step">
                    <div class="funnel-label-left">Total with migraine</div>
                    <div class="funnel-bar-container">
                        <div class="funnel-bar clickable" style="width: 100%; max-width: 620px; background: var(--purple-deep);" onclick="openPanel('stage-1')">~39,000,000</div>
                    </div>
                    <div class="funnel-label-right"></div>
                </div>
                <div class="funnel-connector"></div>

                <!-- Step 2 -->
                <div class="funnel-step">
                    <div class="funnel-label-left">Diagnosed</div>
                    <div class="funnel-bar-container">
                        <div class="funnel-bar clickable" style="width: 62%; max-width: 384px; background: var(--purple-primary);" onclick="openPanel('stage-1')">~24,000,000</div>
                    </div>
                    <div class="funnel-label-right">
                        <span class="dropoff">â†“ ~38% lost</span>
                        <span class="driver">Awareness, stigma, access</span>
                    </div>
                </div>
                <div class="funnel-connector"></div>

                <!-- Step 3 -->
                <div class="funnel-step">
                    <div class="funnel-label-left">Prescribed a CGRP/gepant</div>
                    <div class="funnel-bar-container">
                        <div class="funnel-bar clickable" style="width: 28%; max-width: 174px; background: var(--purple-mid);" onclick="openPanel('stage-2')">~3â€“4M</div>
                    </div>
                    <div class="funnel-label-right">
                        <span class="dropoff">â†“ ~57â€“60% lost</span>
                        <span class="driver">Prescriber inertia, specialist shortage</span>
                    </div>
                </div>
                <div class="funnel-connector"></div>

                <!-- Step 4 -->
                <div class="funnel-step">
                    <div class="funnel-label-left">PA approved</div>
                    <div class="funnel-bar-container">
                        <div class="funnel-bar clickable" style="width: 22%; max-width: 136px; background: var(--amber-accent);" onclick="openPanel('stage-3')">~2.4â€“3.2M</div>
                    </div>
                    <div class="funnel-label-right">
                        <span class="dropoff">â†“ ~20% lost</span>
                        <span class="driver">PA friction, denials</span>
                    </div>
                </div>
                <div class="funnel-connector"></div>

                <!-- Step 5 -->
                <div class="funnel-step">
                    <div class="funnel-label-left">Filled at pharmacy</div>
                    <div class="funnel-bar-container">
                        <div class="funnel-bar clickable" style="width: 15%; max-width: 93px; background: #D4740E;" onclick="openPanel('stage-4')">~1.4â€“2.2M</div>
                    </div>
                    <div class="funnel-label-right">
                        <span class="dropoff">â†“ ~30â€“40% lost</span>
                        <span class="driver">Cost shock, abandonment</span>
                    </div>
                </div>
                <div class="funnel-connector"></div>

                <!-- Step 6 -->
                <div class="funnel-step">
                    <div class="funnel-label-left">On therapy at 12 months</div>
                    <div class="funnel-bar-container">
                        <div class="funnel-bar clickable" style="width: 8%; max-width: 68px; background: var(--red-accent); font-size: 0.9rem; min-width: 68px;" onclick="openPanel('stage-5')">~575K</div>
                    </div>
                    <div class="funnel-label-right">
                        <span class="dropoff">â†“ ~45% lost</span>
                        <span class="driver">Cost, non-response, PA renewal gaps</span>
                    </div>
                </div>
            </div>

            <div class="bottom-line fade-in">
                <div class="big-ratio">1 in 14</div>
                <p>Of the 7â€“10 million Americans clinically appropriate for CGRP/gepant therapy â€” patients who've failed other treatments â€” only about 575,000 are on continuous therapy at any given time.</p>
            </div>
        </section>

        <section class="map-section">
            <div class="section-header">
                <h2>The Diagnosis Gap, Mapped</h2>
                <p>15.3 million Americans with migraine remain undiagnosed. Geographic disparities in care access leave entire communities without treatment.</p>
            </div>
            <div class="map-container">
                <iframe src="https://online.caliper.com/mas-795-ljp-686-hnx/maps/ml10nkl8009r3zaq8jgq" title="Undiagnosed Migraine Patients by ZIP Code"></iframe>
            </div>
            <p class="map-caption">Interactive map: Estimated undiagnosed migraine patients by ZIP code</p>
        </section>

        <section class="stage-details">
            <div class="stage-panel" id="stage-1">
                <button class="stage-toggle" onclick="togglePanel('stage-1')">
                    <div class="stage-number">1</div>
                    <div class="stage-toggle-text">
                        <h3>Getting Diagnosed</h3>
                        <p class="stage-subtitle">~15 million Americans with migraine have never been diagnosed</p>
                    </div>
                    <span class="stage-arrow">â–¾</span>
                </button>
                <div class="stage-content">
                    <div class="stage-content-inner">
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Undiagnosed migraine</div>
                                <div class="barrier-impact">Of ~39 million Americans with migraine, approximately 15.3 million have never received a diagnosis.</div>
                            </div>
                            <div class="barrier-source">American Migraine Foundation</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Specialist shortage</div>
                                <div class="barrier-impact">Only 564 UCNS-accredited headache specialists serve ~39 million patients. The field needs at least 3,700.</div>
                            </div>
                            <div class="barrier-source">Headache journal; AHS</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Wait times</div>
                                <div class="barrier-impact">Average 3.7 months for a first specialist visit â€” up to 14 months in some areas.</div>
                            </div>
                            <div class="barrier-source">Kainth et al., Neurology &amp; Therapy (2020)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Primary care knowledge gap</div>
                                <div class="barrier-impact">Medical school devotes roughly 3 hours to headache education, yet 52.8% of migraine encounters happen in primary care.</div>
                            </div>
                            <div class="barrier-source">AHS; Medscape/AHS 2024</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Stigma and minimization</div>
                                <div class="barrier-impact">Patients don't seek care and providers dismiss symptoms as "just headaches."</div>
                            </div>
                            <div class="barrier-source">AHS; American Migraine Foundation</div>
                        </div>
                    </div>
                </div>
            </div>

            <div class="stage-panel" id="stage-2">
                <button class="stage-toggle" onclick="togglePanel('stage-2')">
                    <div class="stage-number">2</div>
                    <div class="stage-toggle-text">
                        <h3>Getting Prescribed the Right Drug</h3>
                        <p class="stage-subtitle">Step therapy mandates and prescriber inertia block escalation to CGRPs</p>
                    </div>
                    <span class="stage-arrow">â–¾</span>
                </button>
                <div class="stage-content">
                    <div class="stage-content-inner">
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Prescriber inertia</div>
                                <div class="barrier-impact">PCPs comfortable with triptans rarely escalate to CGRPs even when clinically indicated.</div>
                            </div>
                            <div class="barrier-source">AHS clinical guidance</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Step therapy requirements</div>
                                <div class="barrier-impact">96% of managed care organizations require trial and failure of at least one non-CGRP preventive before approval. 56% require two or more.</div>
                            </div>
                            <div class="barrier-source">AJMC MCO analysis (2025)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Outdated insurer policies</div>
                                <div class="barrier-impact">Insurers still require step therapy despite the AHS 2024 position statement recommending CGRPs as first-line treatment.</div>
                            </div>
                            <div class="barrier-source">AHS Position Statement (2024)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">No standardization across plans</div>
                                <div class="barrier-impact">Every health plan has its own prior authorization criteria â€” no two are alike.</div>
                            </div>
                            <div class="barrier-source">AJMC; Dr. Maria Lopes, MD</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Documentation errors</div>
                                <div class="barrier-impact">Incomplete or incorrect PA submissions are a leading cause of denial. Staff frequently skip unanswered questions.</div>
                            </div>
                            <div class="barrier-source">Dr. Vera Gibb, AMD (2023)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Wrong diagnosis codes</div>
                                <div class="barrier-impact">Overly specific ICD codes like "ocular migraine" trigger denials when they aren't in payer dropdown menus.</div>
                            </div>
                            <div class="barrier-source">Dr. Vera Gibb, AMD (2023)</div>
                        </div>
                    </div>
                </div>
            </div>

            <div class="stage-panel" id="stage-3">
                <button class="stage-toggle" onclick="togglePanel('stage-3')">
                    <div class="stage-number">3</div>
                    <div class="stage-toggle-text">
                        <h3>Getting the Prescription Approved</h3>
                        <p class="stage-subtitle">96% of CGRPs require prior authorization â€” and denials are common</p>
                    </div>
                    <span class="stage-arrow">â–¾</span>
                </button>
                <div class="stage-content">
                    <div class="stage-content-inner">
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">PA required for nearly all CGRPs</div>
                                <div class="barrier-impact">96% of managed care organizations require prior authorization for CGRP antagonists.</div>
                            </div>
                            <div class="barrier-source">AJMC (2025)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Processing delays</div>
                                <div class="barrier-impact">Average 2â€“5 business days for PA processing; specialty drugs often longer.</div>
                            </div>
                            <div class="barrier-source">AMA Prior Auth Survey</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Denial on first submission</div>
                                <div class="barrier-impact">Significant initial denial rates, especially for incomplete submissions.</div>
                            </div>
                            <div class="barrier-source">AJMC; Dr. Vera Gibb</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">7% of all Rx claims rejected by PA</div>
                                <div class="barrier-impact">Of those rejections, 37% are abandoned entirely â€” the prescription is never filled.</div>
                            </div>
                            <div class="barrier-source">Medication Access Report (2020)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Appeal complexity</div>
                                <div class="barrier-impact">Multi-step appeal processes cause many providers and patients to give up.</div>
                            </div>
                            <div class="barrier-source">American Migraine Foundation</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Renewal friction</div>
                                <div class="barrier-impact">PA approvals typically expire every 6â€“12 months, requiring full re-documentation.</div>
                            </div>
                            <div class="barrier-source">FEP Blue PA policies (2024)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Specialist-only restrictions</div>
                                <div class="barrier-impact">Some plans require CGRP prescriptions from headache specialists â€” and some states don't have any.</div>
                            </div>
                            <div class="barrier-source">Shoshana Lipson, AJMC</div>
                        </div>
                    </div>
                </div>
            </div>

            <div class="stage-panel" id="stage-4">
                <button class="stage-toggle" onclick="togglePanel('stage-4')">
                    <div class="stage-number">4</div>
                    <div class="stage-toggle-text">
                        <h3>Filling the Prescription</h3>
                        <p class="stage-subtitle">Cost shock at the pharmacy drives 30â€“40% abandonment</p>
                    </div>
                    <span class="stage-arrow">â–¾</span>
                </button>
                <div class="stage-content">
                    <div class="stage-content-inner">
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Sticker shock</div>
                                <div class="barrier-impact">CGRP wholesale cost runs ~$1,200/month ($14,400/year). Without copay assistance, patients face $500â€“$700+/month out of pocket.</div>
                            </div>
                            <div class="barrier-source">AbbVie WAC data (Jan 2026)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Cost-driven abandonment</div>
                                <div class="barrier-impact">Cost sharing above $100 is associated with abandonment rates up to 75% for specialty drugs.</div>
                            </div>
                            <div class="barrier-source">JMCP systematic review (2023)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Copay assistance unawareness</div>
                                <div class="barrier-impact">Manufacturer programs can reduce costs to $0â€“$10/month, but many patients never learn they exist.</div>
                            </div>
                            <div class="barrier-source">Assoc. of Migraine Disorders (2025)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Medicare/Medicaid exclusion</div>
                                <div class="barrier-impact">Government-insured patients are ineligible for manufacturer copay assistance programs.</div>
                            </div>
                            <div class="barrier-source">Federal law; PAN Foundation</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Formulary tier placement</div>
                                <div class="barrier-impact">CGRPs are typically placed on specialty tiers (Tier 4+) with 25â€“33% coinsurance instead of flat copays.</div>
                            </div>
                            <div class="barrier-source">CMS formulary data; DLA Piper (2026)</div>
                        </div>
                    </div>
                </div>
            </div>

            <div class="stage-panel" id="stage-5">
                <button class="stage-toggle" onclick="togglePanel('stage-5')">
                    <div class="stage-number">5</div>
                    <div class="stage-toggle-text">
                        <h3>Staying on Treatment</h3>
                        <p class="stage-subtitle">45% of patients discontinue within 12 months</p>
                    </div>
                    <span class="stage-arrow">â–¾</span>
                </button>
                <div class="stage-content">
                    <div class="stage-content-inner">
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">45% discontinue within 12 months</div>
                                <div class="barrier-impact">Pooled 12-month CGRP monoclonal antibody adherence is ~55%. Oral preventives are even worse at ~14%.</div>
                            </div>
                            <div class="barrier-source">Cureus review, 11 studies (2025)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">PA expiration gaps</div>
                                <div class="barrier-impact">Lapsed prior authorizations create gaps in medication supply. Many patients never restart.</div>
                            </div>
                            <div class="barrier-source">FEP Blue; provider reports</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Injection aversion</div>
                                <div class="barrier-impact">Self-injection barriers drive some patients away from monoclonal antibodies, though oral gepants are growing 61% year-over-year.</div>
                            </div>
                            <div class="barrier-source">Market data (Qulipta trends)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Non-response to first CGRP</div>
                                <div class="barrier-impact">~25% of patients don't achieve a clinically meaningful response to the first CGRP they try.</div>
                            </div>
                            <div class="barrier-source">Burgalassi et al., Cephalalgia (2024)</div>
                        </div>
                        <div class="barrier-item">
                            <div>
                                <div class="barrier-name">Loss to follow-up</div>
                                <div class="barrier-impact">Patients doing well cancel appointments. Without a provider visit, PA renewals lapse.</div>
                            </div>
                            <div class="barrier-source">Dr. Vera Gibb, AMD</div>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <section class="sources-section">
            <div class="sources-inner">
                <h2>Sources</h2>
                <p>AJMC Â· American Headache Society Â· American Migraine Foundation Â· AMA Â· Association of Migraine Disorders Â· CMS Â· Cureus Â· DLA Piper Â· FEP Blue Â· Journal of Headache and Pain Â· JMCP Â· Kainth et al. (Neurology &amp; Therapy) Â· Medscape Â· NeurologyLive Â· PAN Foundation Â· Manufacturer earnings reports (Pfizer, AbbVie, Eli Lilly, Amgen). All figures represent best available estimates from published literature and public data. Last updated February 2026.</p>
            </div>
        </section>

        <section class="page-cta">
            <h2>This Is the Problem We're Solving</h2>
            <p>The Headache Vault automates the prior authorization process so clinicians can focus on patients â€” not paperwork.</p>
            <a href="index.html#demo" class="btn btn-white">Try the PA Engine Beta â†’</a>
        </section>
    </main>

    <footer>
        <p>Â© 2026 The Headache Vault Â· <a href="index.html">Home</a></p>
    </footer>

    <script>
        function togglePanel(id) {
            const panel = document.getElementById(id);
            panel.classList.toggle('open');
        }

        function openPanel(id) {
            const panel = document.getElementById(id);
            if (!panel.classList.contains('open')) {
                panel.classList.add('open');
            }
            panel.scrollIntoView({ behavior: 'smooth', block: 'start' });
        }

        // Fade-in on scroll
        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    entry.target.classList.add('visible');
                }
            });
        }, { threshold: 0.15 });

        document.querySelectorAll('.fade-in').forEach(el => observer.observe(el));
    </script>
</body>
</html>
